Interleukin-22: A potential immunomodulatory molecule in the lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 2 I, 2004, Pages 220-226

  Whittington, Hayley A ^a   Armstrong, Lynne ^a   Uppington, Kay M ^a   Millar, Ann B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; INTERSTITIAL LUNG DISEASE; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; SARCOIDOSIS; TISSUE SECTION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 4143111309     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0285OC     Document Type: Article

References (32)

1. Martinez, J. A., T. E. King, Jr., K. Brown, C. A. Jennings, L. Borish, R. L. Mortenson, T. Z. Khan, T. W. Bost, and D. W. Riches. 1997. Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. Am. J. Physiol. 273:L676-L683.
2. Zhang, Y., T. C. Lee, B. Guillemin, M. C. Yu, and W. N. Rom. 1993. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 150:4188-4196.
3. Freeburn, R. W., L. Armstrong, and A. B. Millar. 1999. Molecular analysis of mRNA levels in cytokines and their receptors in patients with cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 159:A659. (Abstr.)
4. Dumoutier, L., J. Louahed, and J. C. Renauld. 2000. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164:1814-1819.
5. Dumoutier, L., E. Van Roost, D. Colau, and J. C. Renauld. 2000. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc. Natl. Acad. Sci. USA 97:10144-10149.
6. Kotenko, S. V., L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka. 2001. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J. Biol. Chem. 276:2725-2732.
7. Xie, M. H., S. Aggarwal, W. H. Ho, J. Foster, Z. Zhang, J. Stinson, W. I. Wood, A. D. Goddard, and A. L. Gurney. 2000. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J. Biol. Chem. 275:31335-31339.
8. Kotenko, S. V., C. D. Krause, L. S. Izotova, B. P. Pollack, W. Wu, and S. Pestka. 1997. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16:5894-5903.
9. Lejeune, D., L. Dumoutier, S. Constantinescu, W. Kruijer, J. J. Schuringa, and J. C. Renauld. 2002. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J. Biol. Chem. 277:33676-33682.
10. Dumoutier, L., D. Lejeune, D. Colau, and J. C. Renauld. 2001. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J. Immunol 166:7090-7095.
11. Kotenko, S. V., L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka. 2001. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 166:7096-7103.
12. Xu, W., S. R. Presnell, J. Parrish-Novak, W. Kindsvogel, S. Jaspers, Z. Chen, S. R. Dillon, Z. Gao, T. Gilbert, K. Madden, S. Schlutsmeyer, L. Yao, T. E. Whitmore, Y. Chandrasekher, F. J. Grant, M. Maurer, L. Jelinek, H. Storey, T. Brender, A. Hammond, S. Topouzis, C. H. Clegg, and D. C. Foster. 2001. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl. Acad. Sci. USA 98:9511-9516.
13. Gruenberg, B. H., A. Schoenemeyer, B. Weiss, L. Toschi, S. Kunz, K. Wolk, K. Asadullah, and R. Sabat. 2001. A novel, soluble homologue of the human IL-10 receptor with preferential expression in placenta. Genes Immun. 2:329-334.
14. Wei, C. C., T. W. Ho, W. G. Liang, G. Y. Chen, and M. S. Chang. 2003. Cloning and characterization of mouse IL-22 binding protein. Genes Immun. 4:204-211.
15. Tachiiri, A., R. Imamura, Y. Wang, M. Fukui, M. Umemura, and T. Suda. 2003. Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun. 4:153-159.
16. Lieber, M., B. Smith, A. Szakal, W. Nelson-Rees, and G. Todaro. 1976. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17:62-70.
17. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, J. R. LeGall, A. Morris, and R. Spragg. 1994. American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149:818-824.
18. Demedts, M., and U. Costabel. 2002. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Eur. Respir. J. 19:794-796.
19. Witherden, I. R., and T. D. Tetley. 2001. Isolation and culture of human alveolar type II pneumocytes. In Human Airway Inflammation: Sampling Techniques and Analytical Protocols. D. F. Rogers and L. E. Donnelly, editors. Humana Press, Totawa, NJ. 137-146.
20. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/ cell kill. J. Immunol. Methods 119:203-210.
21. Delclaux, C., M. P. D'Ortho, C. Delacourt, F. Lebargy, C. Brun-Buisson, L. Brochard, F. Lemaire, C. Lafuma, and A. Harf. 1997. Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am. J. Physiol. 272:L442-L451.
22. Gudmundsson, G., and G. W. Hunninghake. 1999. Respiratory epithelial cells release interleukin-8 in response to a thermophilic bacteria that causes hypersensitivity pneumonitis. Exp. Lung Res. 25:217-228.
23. Pilette, C., Y. Ouadrhiri, J. Van Snick, J. C. Renauld, P. Staquet, J. P. Vaerman, and Y. Sibille. 2002. Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9. Eur. Respir. J. 20:1198-1205.
24. Muller-Quernheim. J. 1998. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur. Respir. J. 12:716-738.
25. Ziegenhagen, M. W., and J. Muller-Quernheim. 2003. The cytokine network in sarcoidosis and its clinical relevance. J. Intern. Med. 253:18-30.
26. Ward, K., C. O'Connor, C. Odium, and M. X. Fitzgerald. 1989. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 44:6-12.
27. Pinkston, P., P. B. Bitterman, and R. G. Crystal. 1983. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N. Engl. J. Med. 308:793-800.
28. Robinson, B. W., T. L. McLemore, and R. G. Crystal. 1985. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J. Clin. Invest. 75:1488-1495.
29. Walker, C., W. Bauer, R. K. Braun, G. Menz, P. Braun, F. Schwarz, T. T. Hansel, and B. Villiger. 1994. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150:1038-1048.
30. Crepaldi, L., L. Silveri, F. Calzetti, C. Pinardi, and M. A. Cassatella. 2002. Molecular basis of the synergistic production of IL-1 receptor antagonist by human neutrophils stimulated with IL-4 and IL-10. Int. Immunol. 14: 1145-1153.
31. Donnelly, R. P., H. Dickensheets, and D. S. Finbloom. 1999. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19:563-573.
32. Donnelly, S. C., R. M. Strieter, S. L. Kunkel, A. Walz, C. R. Robertson, D. C. Carter, I. S. Grant, A. J. Pollok, and C. Haslett. 1993. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643-647.